The purpose of this study is to characterize the circadian rhythm disruption experienced by patients as determined by plasma melatonin, cortisol, and other circadian analytes
Study Type
OBSERVATIONAL
Enrollment
8
Unnamed facility
Baltimore, Maryland, United States
Circadian melatonin rhythm as measured by plasma melatonin
Time frame: 36-hour blood sampling on week 1
Circadian melatonin rhythm as measured by plasma melatonin
Time frame: 36-hour blood sampling on week 2
Circadian melatonin rhythm as measured by plasma melatonin
Time frame: 36-hour blood sampling on week 4
Circadian cortisol rhythms as measured by plasma cortisol
Time frame: 36-hour blood sampling at week 1
Circadian cortisol rhythms as measured by plasma cortisol
Time frame: 36-hour blood sampling at week 2
Circadian cortisol rhythms as measured by plasma cortisol
Time frame: 36-hour blood sampling at week 4
Circadian analytes rhythms as measured in plasma
Time frame: 36-hour blood sampling at week 1
Circadian analytes rhythms as measured in plasma
Time frame: 36-hour blood sampling at week 2
Circadian analytes rhythms as measured in plasma
Time frame: 36-hour blood sampling at week 4
Genetic testing to confirm SMS diagnosis
Time frame: blood sampling at screening visit
Nighttime and daytime sleep as measured by actigraphy
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: Four week evaluation period
QOL Scale
Time frame: Four week evaluation period
Melatonin Light Response Test (MLRT)
Time frame: After four week evaluation period
Behavioral Scale
Time frame: Four week evaluation period
Salivary melatonin and cortisol
Time frame: Four week evaluation period